Pathology Update: State-of-the-Art Diagnostic Approaches to Surgical Pathology 2017
In-Person Event
Jul 24 - 28, 2017
Las Vegas, Nevada, USA
OVERVIEW
Pathology Update: State-of-the-Art Diagnostic Approaches to Surgical Pathology is organized by American Society for Clinical Pathology (ASCP) and would be held during Jul 24 - 28, 2017 at The Venetian Las Vegas, Las Vegas, Nevada, United States of America.
The target audience for this medical event are Pathologists, Pathology Residents, and Pathologists’ Assistants. This CME conference has been approved with 33.75 CME Credits.
Following this course, you will be able to:
• Discuss the features that allow separation of benign from malignant mesothelial proliferations; explain current issues in the diagnosis of lung cancer; and describe problem areas in interstitial lung disease.
• Accurately assign and report the Gleason score of prostatic adenocarcinoma using the current recommendations of the International Society of Urologic Pathology and describe the key pathologic features that should be included in a pathology report of urothelial carcinoma of the urinary bladder.
• Explain the relevancy of molecular testing to molecular pathology and the meaning of testing results; discuss the influence of molecular testing on the diagnosis, disease surveillance, and therapeutic choices for various organ systems; describe in general the current guidelines for tumor types that will necessitate molecular testing; and discuss molecular alterations in lung, thyroid, and colorectal cancer and in gliomas, mesothelioma, and soft tissue tumors.
• Apply a judicious panel of immunohistochemistry (IHC) stains in the setting of an unknown tumor type; apply a directed panel of transcription-factor-centric immunostains to identify the site of origin for a metastatic carcinoma of unknown primary; recognize potential pitfalls in IHC stain interpretation and apply best practices to IHC stain implementation in your laboratory.
• Discuss the diagnostic criteria for lesions of the thyroid, salivary glands, and mucosal lining of the upper aerodigestive tract and explain recurrent molecular alterations in head and neck neoplasia.
• Reduce/eliminate error in breast pathology diagnosis through an awareness of diagnostic pitfalls and the related resolutions, using conventional microscopy and appropriate adjunctive diagnostic techniques.
Additional details will be posted as soon as they are available.
The target audience for this medical event are Pathologists, Pathology Residents, and Pathologists’ Assistants. This CME conference has been approved with 33.75 CME Credits.
Following this course, you will be able to:
• Discuss the features that allow separation of benign from malignant mesothelial proliferations; explain current issues in the diagnosis of lung cancer; and describe problem areas in interstitial lung disease.
• Accurately assign and report the Gleason score of prostatic adenocarcinoma using the current recommendations of the International Society of Urologic Pathology and describe the key pathologic features that should be included in a pathology report of urothelial carcinoma of the urinary bladder.
• Explain the relevancy of molecular testing to molecular pathology and the meaning of testing results; discuss the influence of molecular testing on the diagnosis, disease surveillance, and therapeutic choices for various organ systems; describe in general the current guidelines for tumor types that will necessitate molecular testing; and discuss molecular alterations in lung, thyroid, and colorectal cancer and in gliomas, mesothelioma, and soft tissue tumors.
• Apply a judicious panel of immunohistochemistry (IHC) stains in the setting of an unknown tumor type; apply a directed panel of transcription-factor-centric immunostains to identify the site of origin for a metastatic carcinoma of unknown primary; recognize potential pitfalls in IHC stain interpretation and apply best practices to IHC stain implementation in your laboratory.
• Discuss the diagnostic criteria for lesions of the thyroid, salivary glands, and mucosal lining of the upper aerodigestive tract and explain recurrent molecular alterations in head and neck neoplasia.
• Reduce/eliminate error in breast pathology diagnosis through an awareness of diagnostic pitfalls and the related resolutions, using conventional microscopy and appropriate adjunctive diagnostic techniques.
Additional details will be posted as soon as they are available.
KEY DATES
24 Jul, 2017
Event Start Date
28 Jul, 2017
Event End Date
SPECIALITIES
SurgeryPathologySUGGESTED HOTELS
CONFERENCE VENUE
The VenetianRELATED CONFERENCES & LIVE WEBINARS
Quick Links